Angitia Biopharmaceuticals raised $120M in a Series C funding led by Bain Capital Life Sciences to fund ongoing trials of its musculoskeletal drug candidates.
Amount Raised
$120 Million
Round Type
Series C
Los AngelesBiotechnologyTherapeuticsInvestors
Description
Angitia Biopharmaceuticals has completed a $120 million Series C funding round to push forward three musculoskeletal trials. Led by Bain Capital Life Sciences, the financing attracted new and existing investors, indicating strong support for Angitia's clinical progress.
Quick answer
Angitia Biopharmaceuticals raised $120 Million in a Series C round, dated December 11, 2024. Investors: Elikon Venture, Orbimed, 3H Health Investment, Legend Capital, Yonghua Capital, Janus Henderson and Bain Capital Life Sciences. Angitia Biopharmaceuticals is based in Los Angeles, California, United States.
- How much did Angitia Biopharmaceuticals raise?
- Angitia Biopharmaceuticals raised $120 Million in a Series C round on December 11, 2024.
- Who invested in Angitia Biopharmaceuticals?
- Elikon Venture, Orbimed, 3H Health Investment, Legend Capital, Yonghua Capital, Janus Henderson and Bain Capital Life Sciences are named as investors in this round.
- What does Angitia Biopharmaceuticals do?
- Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing novel therapies aimed at improving musculoskeletal health.
- Where is Angitia Biopharmaceuticals based and how big is it?
- Angitia Biopharmaceuticals is based in Los Angeles, California, United States. Fundz records about 51 employees.
- Who are the decision-makers at Angitia Biopharmaceuticals?
- Fundz holds 1 contact at Angitia Biopharmaceuticals, including the Founder and CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Angitia Biopharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Dermata Therapeutics raised $2.5M (Seed) on January 21, 2025.
- Phio Pharmaceuticals raised $153K (Seed) on January 17, 2025.
- VisiRose raised $3M (Seed) on January 16, 2025.
- Phio Pharmaceuticals raised $208K (Seed) on January 15, 2025.
- Phio Pharmaceuticals raised $266K (Seed) on January 14, 2025.
- Umoja Biopharma raised $100M (Series C) on January 14, 2025.
Who to call at Angitia Biopharmaceuticals, and when
A new round usually means Angitia Biopharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Angitia Biopharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Angitia Biopharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Angitia Biopharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Angitia Biopharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Angitia Biopharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.